Skip to main content
. 2024 Mar 16;25(2):bbae098. doi: 10.1093/bib/bbae098

Table 3.

Potential biomarkers from proteomics studies in various MH-related disorders

Author name or study ID Disorder Protein(s)/biological functions affected Implications Source
[22] AD GAPDH Interaction with β-amyloid precursor protein [22] Various
[24] AD Respiratory mitochondrial complex subunits including those from the NDUFA and NDUFB subunits of the enzyme NADH dehydrogenase Mitochondrial proteomic differences in early-onset and late-onset AD [24] Brain tissue
Multiple studies: Moya-Alvarado et al. [25–27] AD Proteins associated with mitochondria, phosphorylation and oxidation Impaired glucose metabolism and energy production [25–27] Multiple studies from blood and brain tissue
Hondius et al. [28] AD Calcium-dependent signaling proteins, extracellular matrix components Protein expression changes in hippocampus [28] Brain
[138] AD Novel peptide sequences identified (SpotLight) Antibody variable region associations with potential to provide disease origin insights [138] Blood
[29] AD Reduced glucose utilization Biomarker for AD detection [29] Brain
Bot et al./Netherlands Study of Depression and Anxiety MDD 171 serum proteins and serum analytes Linked to diverse cell communication, signal transduction processes, immune response and protein metabolism [30] Serum
Gellen et al. MDD Changes in protein abundance Linked to several biological functions, including inflammation, transcription, cell metabolism and cytoskeleton organization [31] Animal model
Comes et al. [139] MDD 141 peptides and analytics analytes with combined m/z 1017, m/z 1042 and m/z 1479 Potential biomarkers Blood
Multiple studies: [32, 140]; [7, 32] MDD DPYSL2 also known as CRMP2; CA2 and ALDOC Regulating axonal guidance, neuronal growth cone collapse and cell migration [32, 140]; energy metabolism [7, 32] Studies from blood and brain tissue
[32] MDD versus SCZ HINT1 increased in MDD and lower in SCZ. Differential protein levels in brain of MDD and SCZ patients Blood and urine
[139] BD Alpha-2-macroglobulin, Apolipoprotein A-I and C4b-binding protein alpha chain, Complement C3, Glutathione-S-transferase A3, hemopexin, Immunoglobulin M, Kit ligand, Macrophage migration inhibitory factor, MMP7 and sex hormone-binding globulin Proteins belonging to the following pathways associated with BD: FXR/RXR activation, LXR/RXR activation, acute phase response signaling, clathrin-mediated endocytosis signaling and atherosclerosis signaling Blood
Ren et al. [34] BD versus MDD Proteins upregulated: B2RAN2, B4E1B2, APOA1, ENG, SBSN and QSOX2. Proteins downregulated: ORM1, MRC2 and SLPI downregulated B2RAN2 and ENG as potential biomarkers to differentiate BD and MDD Blood plasma
Ristori et al. [10] ASD (APOE and APOA1) and (FN1) Large presence of apolipoproteins proteins and fibronectin Studies from blood and brain tissue
Junaid et al. [141] ASD Glyoxalase I (Glo1) [141] Increase in polarity Brain
[35] SCZ, ASD and BD p140Cap protein interactome network associated with the SRCIN1 gene Common interactome network Various